STOCK TITAN

[SCHEDULE 13G] Walgreens Boots Alliance, Inc SEC Filing

Filing Impact
(Low)
Filing Sentiment
(Neutral)
Form Type
SCHEDULE 13G

Silver Point Capital and two principals filed a Schedule 13G regarding Walgreens Boots Alliance (WBA). The filing states that as of August 27, 2025 the Reporting Persons beneficially owned 60,061,000 shares, representing 6.9% of 865,560,675 shares outstanding (per the issuer's June 19, 2025 count). The issuer completed a merger on August 28, 2025 and the Reporting Persons' shares were converted into the stated Per Share Consideration. The cover pages list 0 shares beneficially owned at filing, reflecting that conversion. The Schedule is jointly filed by Silver Point Capital, L.P., Edward A. Mule and Robert J. O'Shea and includes a Joint Filing Agreement.

Silver Point Capital e due soci hanno depositato un Schedule 13G relativo a Walgreens Boots Alliance (WBA). Il documento dichiara che al 27 agosto 2025 le Persone che riportano la comunicazione detenevano in via beneficiaria 60.061.000 azioni, pari a 6,9% di 865.560.675 azioni in circolazione (secondo il conteggio dell'emittente del 19 giugno 2025). L'emittente ha completato una fusione il 28 agosto 2025 e le azioni delle Persone che riportano sono state convertite nel Per Share Consideration indicato. Le prime pagine copertina segnalano 0 azioni detenute al momento del deposito, a seguito di tale conversione. Lo Schedule è presentato congiuntamente da Silver Point Capital, L.P., Edward A. Mule e Robert J. O'Shea e include un accordo di deposito congiunto.

Silver Point Capital y dos directivos presentaron un Schedule 13G sobre Walgreens Boots Alliance (WBA). La presentación indica que al 27 de agosto de 2025 las Personas Informantes poseían de forma beneficiaria 60.061.000 acciones, lo que representa 6,9% de 865.560.675 acciones en circulación (según el conteo del emisor del 19 de junio de 2025). El emisor completó una fusión el 28 de agosto de 2025 y las acciones de las Personas Informantes se convirtieron en la Per Share Consideration indicada. Las páginas de portada reflejan 0 acciones poseídas al presentar el documento, consecuencia de dicha conversión. El Schedule se presenta conjuntamente por Silver Point Capital, L.P., Edward A. Mule y Robert J. O'Shea e incluye un Acuerdo de Presentación Conjunta.

Silver Point Capital와 두 명의 주요 인사가 Walgreens Boots Alliance(WBA)에 관한 Schedule 13G를 제출했습니다. 제출서에 따르면 신고인은 2025년 8월 27일 기준으로 60,061,000주의 실질적 소유권을 보유하고 있었으며, 이는 발행주식 865,560,675주의 6.9%에 해당합니다(발행사의 2025년 6월 19일 집계 기준). 발행회사는 2025년 8월 28일 합병을 완료했고 신고인의 주식은 공시된 Per Share Consideration으로 전환되었습니다. 표지 페이지에는 해당 전환을 반영하여 제출 시점의 0주 보유로 기재되어 있습니다. 이 Schedule은 Silver Point Capital, L.P., Edward A. Mule 및 Robert J. O'Shea가 공동으로 제출했으며 공동 제출 계약을 포함합니다.

Silver Point Capital et deux dirigeants ont déposé un Schedule 13G concernant Walgreens Boots Alliance (WBA). Le dépôt indique qu'au 27 août 2025, les personnes déclarante bénéficiaient de 60 061 000 actions, représentant 6,9% des 865 560 675 actions en circulation (selon le décompte de l'émetteur au 19 juin 2025). L'émetteur a finalisé une fusion le 28 août 2025 et les actions des personnes déclarante ont été converties en la Per Share Consideration indiquée. Les pages de couverture mentionnent 0 actions détenues au moment du dépôt, reflétant cette conversion. Le Schedule est déposé conjointement par Silver Point Capital, L.P., Edward A. Mule et Robert J. O'Shea et inclut un accord de dépôt conjoint.

Silver Point Capital und zwei leitende Personen reichten ein Schedule 13G für Walgreens Boots Alliance (WBA) ein. In der Einreichung heißt es, dass die meldenden Personen zum 27. August 2025 wirtschaftlich 60.061.000 Aktien hielten, was 6,9% von insgesamt 865.560.675 ausstehenden Aktien entspricht (laut Zählung des Emittenten vom 19. Juni 2025). Der Emittent schloss am 28. August 2025 eine Fusion ab und die Aktien der meldenden Personen wurden in die angegebene Per Share Consideration umgewandelt. Die Titelseiten weisen aufgrund dieser Umwandlung 0 Aktien als zum Zeitpunkt der Einreichung gehalten aus. Das Schedule wird gemeinsam von Silver Point Capital, L.P., Edward A. Mule und Robert J. O'Shea eingereicht und enthält eine gemeinsame Einreichungsvereinbarung.

Positive
  • Disclosed a material pre-merger stake of 60,061,000 shares, equal to 6.9% of outstanding common stock as of June 19, 2025
  • Joint Filing Agreement executed and filed, clarifying reporting coordination among Silver Point, Edward Mule and Robert O'Shea
  • Provides clear post-transaction status noting the shares were converted in the merger closed August 28, 2025
Negative
  • Cover pages report 0 shares beneficially owned, indicating the Reporting Persons do not hold the issuer's common stock following conversion into merger consideration
  • Filing lacks detail on the form and value of the Per Share Consideration received upon conversion (terms referenced but not disclosed in this document)

Insights

TL;DR: Silver Point held a material 6.9% stake pre-merger; post-closing the equity was converted and the filing reports zero retained shares.

Silver Point and affiliated principals disclosed ownership of 60,061,000 shares equal to 6.9% of outstanding WBA as of June 19, 2025. The filing notes a corporate merger closed August 28, 2025 and that the shares were converted into the merger consideration, which explains the zero share figures on the cover pages. For investors, the key datapoints are the pre-closing stake size and the fact that ownership was extinguished or transformed by the merger consideration rather than remaining as ordinary shares.

TL;DR: The joint 13G discloses coordinated reporting and confirms compliance with joint filing rules; conversion of shares removes prior passive stake.

The Reporting Persons executed a Joint Filing Agreement and filed under Rule 13d-1. The statement certifies the holdings were not intended to influence control. Material disclosure elements include the identity of Reporting Persons, their Delaware/U.S. organization status, the exact pre-merger share count and the conversion upon merger close. The document provides procedural transparency about ownership and the post-merger status of those holdings.

Silver Point Capital e due soci hanno depositato un Schedule 13G relativo a Walgreens Boots Alliance (WBA). Il documento dichiara che al 27 agosto 2025 le Persone che riportano la comunicazione detenevano in via beneficiaria 60.061.000 azioni, pari a 6,9% di 865.560.675 azioni in circolazione (secondo il conteggio dell'emittente del 19 giugno 2025). L'emittente ha completato una fusione il 28 agosto 2025 e le azioni delle Persone che riportano sono state convertite nel Per Share Consideration indicato. Le prime pagine copertina segnalano 0 azioni detenute al momento del deposito, a seguito di tale conversione. Lo Schedule è presentato congiuntamente da Silver Point Capital, L.P., Edward A. Mule e Robert J. O'Shea e include un accordo di deposito congiunto.

Silver Point Capital y dos directivos presentaron un Schedule 13G sobre Walgreens Boots Alliance (WBA). La presentación indica que al 27 de agosto de 2025 las Personas Informantes poseían de forma beneficiaria 60.061.000 acciones, lo que representa 6,9% de 865.560.675 acciones en circulación (según el conteo del emisor del 19 de junio de 2025). El emisor completó una fusión el 28 de agosto de 2025 y las acciones de las Personas Informantes se convirtieron en la Per Share Consideration indicada. Las páginas de portada reflejan 0 acciones poseídas al presentar el documento, consecuencia de dicha conversión. El Schedule se presenta conjuntamente por Silver Point Capital, L.P., Edward A. Mule y Robert J. O'Shea e incluye un Acuerdo de Presentación Conjunta.

Silver Point Capital와 두 명의 주요 인사가 Walgreens Boots Alliance(WBA)에 관한 Schedule 13G를 제출했습니다. 제출서에 따르면 신고인은 2025년 8월 27일 기준으로 60,061,000주의 실질적 소유권을 보유하고 있었으며, 이는 발행주식 865,560,675주의 6.9%에 해당합니다(발행사의 2025년 6월 19일 집계 기준). 발행회사는 2025년 8월 28일 합병을 완료했고 신고인의 주식은 공시된 Per Share Consideration으로 전환되었습니다. 표지 페이지에는 해당 전환을 반영하여 제출 시점의 0주 보유로 기재되어 있습니다. 이 Schedule은 Silver Point Capital, L.P., Edward A. Mule 및 Robert J. O'Shea가 공동으로 제출했으며 공동 제출 계약을 포함합니다.

Silver Point Capital et deux dirigeants ont déposé un Schedule 13G concernant Walgreens Boots Alliance (WBA). Le dépôt indique qu'au 27 août 2025, les personnes déclarante bénéficiaient de 60 061 000 actions, représentant 6,9% des 865 560 675 actions en circulation (selon le décompte de l'émetteur au 19 juin 2025). L'émetteur a finalisé une fusion le 28 août 2025 et les actions des personnes déclarante ont été converties en la Per Share Consideration indiquée. Les pages de couverture mentionnent 0 actions détenues au moment du dépôt, reflétant cette conversion. Le Schedule est déposé conjointement par Silver Point Capital, L.P., Edward A. Mule et Robert J. O'Shea et inclut un accord de dépôt conjoint.

Silver Point Capital und zwei leitende Personen reichten ein Schedule 13G für Walgreens Boots Alliance (WBA) ein. In der Einreichung heißt es, dass die meldenden Personen zum 27. August 2025 wirtschaftlich 60.061.000 Aktien hielten, was 6,9% von insgesamt 865.560.675 ausstehenden Aktien entspricht (laut Zählung des Emittenten vom 19. Juni 2025). Der Emittent schloss am 28. August 2025 eine Fusion ab und die Aktien der meldenden Personen wurden in die angegebene Per Share Consideration umgewandelt. Die Titelseiten weisen aufgrund dieser Umwandlung 0 Aktien als zum Zeitpunkt der Einreichung gehalten aus. Das Schedule wird gemeinsam von Silver Point Capital, L.P., Edward A. Mule und Robert J. O'Shea eingereicht und enthält eine gemeinsame Einreichungsvereinbarung.






Check the appropriate box to designate the rule pursuant to which this Schedule is filed:
Rule 13d-1(b)
Rule 13d-1(c)
Rule 13d-1(d)






SCHEDULE 13G




Comment for Type of Reporting Person: Explanatory Note: As of August 27, 2025, the Reporting Persons beneficially owned 60,061,000 shares of the issuer's common stock representing 6.9% of its outstanding common stock based upon 865,560,675 of the issuer's common stock outstanding as of June 19, 2025, as disclosed in the issuer's Quarterly Report on Form 10-Q filed with the Securities and Exchange Commission on June 26, 2025. On August 28, 2025, the issuer's Merger closed, and the shares beneficially owned by the Reporting Persons were converted into the Per Share Consideration, with such terms defined and discussed more fully in the issuer's Current Report on Form 8-K filed with the Securities and Exchange Commission on August 28, 2025.


SCHEDULE 13G




Comment for Type of Reporting Person: Explanatory Note: As of August 27, 2025, the Reporting Persons beneficially owned 60,061,000 shares of the issuer's common stock representing 6.9% of its outstanding common stock based upon 865,560,675 of the issuer's common stock outstanding as of June 19, 2025, as disclosed in the issuer's Quarterly Report on Form 10-Q filed with the Securities and Exchange Commission on June 26, 2025. On August 28, 2025, the issuer's Merger closed, and the shares beneficially owned by the Reporting Persons were converted into the Per Share Consideration, with such terms defined and discussed more fully in the issuer's Current Report on Form 8-K filed with the Securities and Exchange Commission on August 28, 2025.


SCHEDULE 13G




Comment for Type of Reporting Person: Explanatory Note: As of August 27, 2025, the Reporting Persons beneficially owned 60,061,000 shares of the issuer's common stock representing 6.9% of its outstanding common stock based upon 865,560,675 of the issuer's common stock outstanding as of June 19, 2025, as disclosed in the issuer's Quarterly Report on Form 10-Q filed with the Securities and Exchange Commission on June 26, 2025. On August 28, 2025, the issuer's Merger closed, and the shares beneficially owned by the Reporting Persons were converted into the Per Share Consideration, with such terms defined and discussed more fully in the issuer's Current Report on Form 8-K filed with the Securities and Exchange Commission on August 28, 2025.


SCHEDULE 13G



Silver Point Capital, L.P.
Signature:/s/ Steven Weiser
Name/Title:Steven Weiser, Authorized Signatory
Date:09/04/2025
Edward A. Mule
Signature:/s/ Steven Weiser
Name/Title:Steven Weiser, Attorney-in-fact
Date:09/04/2025
Robert J. O'Shea
Signature:/s/ Steven Weiser
Name/Title:Steven Weiser, Attorney-in-fact
Date:09/04/2025
Exhibit Information

Exhibit Index Exhibit A Joint Filing Agreement dated September 4, 2025 Exhibit B Power of Attorney of Edward A. Mule (incorporated here by reference to Exhibit B to Schedule 13G filed by Silver Point Capital, L.P., Edward A. Mule and Robert J. O'Shea with the Securities and Exchange Commission on February 16, 2016 relating to TopBuild Corp.). Exhibit C Power of Attorney of Robert J. O'Shea (incorporated here by reference to Exhibit B to Schedule 13G filed by Silver Point Capital, L.P., Edward A. Mule and Robert J. O'Shea with the Securities and Exchange Commission on February 16, 2016 relating to TopBuild Corp.).

FAQ

How many WBA shares did Silver Point beneficially own before the merger?

60,061,000 shares, representing 6.9% of 865,560,675 shares outstanding as of June 19, 2025

Why do the cover pages list 0 shares for the Reporting Persons?

Because the issuer's merger closed on August 28, 2025 and the Reporting Persons' shares were converted into the Per Share Consideration, leaving them with 0 common shares at filing

Who filed this Schedule 13G for WBA?

Silver Point Capital, L.P., together with Edward A. Mule and Robert J. O'Shea, filing jointly under a Joint Filing Agreement dated September 4, 2025

Does the filing state the Reporting Persons sought to influence control of WBA?

No. The certification states the securities were not acquired or held for the purpose of changing or influencing control of the issuer

When did the merger that affected these holdings close?

August 28, 2025

What outstanding share count was used to compute the 6.9% figure?

865,560,675 shares outstanding as disclosed by the issuer as of June 19, 2025
Walgreen Boots

NASDAQ:WBA

WBA Rankings

WBA Latest News

WBA Latest SEC Filings

WBA Stock Data

10.37B
710.98M
17.44%
60.94%
2.61%
Pharmaceutical Retailers
Retail-drug Stores and Proprietary Stores
Link
United States
DEERFIELD